Literature DB >> 30256679

Improved glucose homeostasis in male obese Zucker rats coincides with enhanced baroreflexes and activation of the nucleus tractus solitarius.

Parul Chaudhary1, Ann M Schreihofer1.   

Abstract

Young adult male obese Zucker rats (OZR) develop insulin resistance and hypertension with impaired baroreflex-mediated bradycardia and activation of nucleus tractus solitarius (NTS). Because type 1 diabetic rats also develop impaired baroreflex-mediated NTS activation, we hypothesized that improving glycemic control in OZR would enhance compromised baroreflexes and NTS activation. Fasting blood glucose measured by telemetry was comparable in OZR and lean Zucker rats (LZR) at 12-17 wk. However, with access to food, OZR were chronically hyperglycemic throughout this age range. By 15-17 wk of age, tail samples yielded higher glucose values than those measured by telemetry in OZR but not LZR, consistent with reports of exaggerated stress responses in OZR. Injection of glucose (1g/kg ip) produced larger rises in glucose and areas under the curve in OZR than LZR. Treatment with metformin (300 mg·kg-1·day-1) or pioglitazone (5 mg·kg-1·day-1) in drinking water for 2-3 wk normalized fed glucose levels in OZR with no effect in LZR. After metformin treatment, area under the curve for blood glucose after glucose injection was reduced in OZR and comparable to LZR. Hyperinsulinemia was slightly reduced by each treatment in OZR, but insulin was still greatly elevated compared with LZR. Neither treatment reduced hypertension in OZR, but both treatments significantly improved the blunted phenylephrine-induced bradycardia and NTS c-Fos expression in OZR with no effect in LZR. These data suggest that restoring glycemic control in OZR enhances baroreflex control of heart rate by improving the response of the NTS to raising arterial pressure, even in the presence of hyperinsulinemia and hypertension.

Entities:  

Keywords:  baroreceptor reflex; hyperglycemia; metabolic syndrome; metformin; pioglitazone

Mesh:

Substances:

Year:  2018        PMID: 30256679      PMCID: PMC6425637          DOI: 10.1152/ajpregu.00195.2018

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  94 in total

Review 1.  Anatomical substrates for baroreflex sympathoinhibition in the rat.

Authors:  S A Aicher; T A Milner; V M Pickel; D J Reis
Journal:  Brain Res Bull       Date:  2000-01-15       Impact factor: 4.077

Review 2.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

3.  Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats.

Authors:  Edgars Liepinsh; Elina Skapare; Baiba Svalbe; Marina Makrecka; Helena Cirule; Maija Dambrova
Journal:  Eur J Pharmacol       Date:  2011-03-01       Impact factor: 4.432

4.  Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry.

Authors:  R K Chan; P E Sawchenko
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

5.  Adrenergic and reflex abnormalities in obesity-related hypertension.

Authors:  G Grassi; G Seravalle; R Dell'Oro; C Turri; G B Bolla; G Mancia
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

6.  Cerebral Cortical Microvascular Rarefaction in Metabolic Syndrome is Dependent on Insulin Resistance and Loss of Nitric Oxide Bioavailability.

Authors:  Paul D Chantler; Carl D Shrader; Lawrence E Tabone; Alexandre C d'Audiffret; Khumara Huseynova; Steven D Brooks; Kayla W Branyan; Kristin A Grogg; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2015-08       Impact factor: 2.628

7.  Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats.

Authors:  J Rouru; R Huupponen; U Pesonen; M Koulu
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

8.  Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity.

Authors:  Eric J Belin de Chantemèle; Mohammed Irfan Ali; James D Mintz; William E Rainey; Michel L Tremblay; David J Fulton; David W Stepp
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

9.  Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension.

Authors:  Louise E Harris; David G Morgan; Nina Balthasar
Journal:  Physiol Rep       Date:  2014-03-20

Review 10.  Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Authors:  Sarah D de Ferranti; Ian H de Boer; Vivian Fonseca; Caroline S Fox; Sherita Hill Golden; Carl J Lavie; Sheela N Magge; Nikolaus Marx; Darren K McGuire; Trevor J Orchard; Bernard Zinman; Robert H Eckel
Journal:  Diabetes Care       Date:  2014-08-11       Impact factor: 19.112

View more
  5 in total

1.  Looking Back on Seven Years of Regulatory, Integrative and Comparative Physiology.

Authors:  Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-02-12       Impact factor: 3.619

2.  AJP-Regulatory, Integrative and Comparative Physiology: Looking Toward the Future.

Authors:  Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-06       Impact factor: 3.619

Review 3.  Obesity, kidney dysfunction, and inflammation: interactions in hypertension.

Authors:  John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

Review 4.  Brain-Body Control of Glucose Homeostasis-Insights From Model Organisms.

Authors:  Alastair J MacDonald; Yu Hsuan Carol Yang; Ana Miguel Cruz; Craig Beall; Kate L J Ellacott
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

5.  Preserved glycemic control and baroreflex efficacy in young adult hypertensive female obese Zucker rats.

Authors:  Parul Chaudhary; Paromita Das-Earl; Ann M Schreihofer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-05-12       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.